Microbix Biosystems Inc (MBXBF)

[yielddude]

My notes from the Annual Meeting webcast 3/31/20 ...

Lots of duplication from the investor presentation the day before, but some other good stuff too.

Microbix is a specialist in infectious diseases (it is their forte). They are considered an essential business in the current environment.

Antigens currently 90% of their business. They have upgraded their production capacity with the introduction of their bioreactors. Their 5th bioreactor just came online (each bioreactor replaces hundreds of roller bottles). Much more efficient, and will reduce costs with higher yields.

QAP's until recently were white label (unbranded), but the Proceedx and Redx are Microbix labels, expect to do greater volumes at higher prices. REally stressing their HPV tests, huge opportunity here. $50M market where Microbix can be a major player.Expecting double to triple digit growth with their QAP's. Unbranded QAP's sell at $10-$20/unit. Newer Microbix labelled Proceedx will be $20-$50/unit, and Redx at $50/unit

If they can partner up and get Kinlytic up and running, foresee market of $200M/yr several years after launch.

With antigen bioreactors at full capacity, will triple sales of antigens.

QAP's at $1M/yr, moving to 10-fold capacity. Leased 2nd site nearby, hoping to have staffed in fall, and in production 1 year from now.

In 5 years, they should be at multiples of today's revenues.

Incredibly bright future.

See for yourself (my notes based on my hearing and transcription ability, not 100%)

Here is link to slide show presentation.
https://cdn.shopify.com/s/files/1/2636/4400/files/MBX_Corporate_Presentation_-_March_2020.pdf?v=1585569336

yield